Medical News

RSS

STARR procedure proposed as alternative operation, noninvasive surgical technique for ODS

Obstructed defecation syndrome represents a widespread clinical problem which frequently affects middle-aged females. Nevertheless, many of the previously established techniques are unsuitable for patients with ODS associated with simultaneous rectocele and rectal intussusception. Notably, STARR has been proposed as an alternative operation and a relatively noninvasive surgical technique for this difficult problem.

3 Jun 2010

Radiation therapy may not improve chances of survival for bladder cancer patients: Study

In the largest study to date of a rare and deadly form of bladder cancer, researchers at Henry Ford Hospital in Detroit found radiation therapy may not improve a patient's chances for survival.

3 Jun 2010

Extracts from peach and plum kill breast cancer cells, say AgriLife Research scientists

Breast cancer cells - even the most aggressive type - died after treatments with peach and plum extracts in lab tests at Texas AgriLife Research recently, and scientists say the results are deliciously promising. Not only did the cancerous cells keel over, but the normal cells were not harmed in the process.

3 Jun 2010

Ocutec receives further equity investment of £500K from existing investors

Ocutec Ltd, the Lanarkshire-based medical devices company, today announced that it had received a further equity investment of £500K from existing investors Discovery Investment Fund Limited, Chimaerabio, Scottish Enterprise Co-investment Fund and company founders.

3 Jun 2010

U-M researchers one step closer to discovering why certain diseases affect specific organs

Why do some diseases affect only specific organs, leaving others invulnerable? Researchers from the University of Michigan have found neural tissue contains imbalanced levels of proteins, which may explain the brain's susceptibility to a debilitating childhood movement disorder.

3 Jun 2010

Data on Nanosphere Verisens PSA assay to be presented at AUA annual meeting

At the annual meeting of the American Urological Association, data using the Nanosphere Verisens™ ultra-sensitive PSA assay (research use only) will be highlighted as one of less than 40 abstracts that were singled out by the Association for a special session for journalists.

3 Jun 2010

Miners' living, working environments fuel spread of TB in sub-Saharan Africa, study says

A study, published Tuesday in the American Journal of Public Health, found that poor living and working environments for miners of diamonds and precious metals is significantly fueling the spread of tuberculosis in sub-Saharan Africa, Reuters reports.

3 Jun 2010

Life Technologies, DKFZ collaborate to create National High-Throughput Sequencing Center

Life Technologies Corporation and the German Cancer Research Center (Deutsches Krebsforschungszentrum or DKFZ) today announced their collaboration to create the National High-Throughput Sequencing Center. This exclusive partnership will create the largest sequencing facility in Germany and the first national sequencing center in Europe dedicated to systems biology.

3 Jun 2010

Case report on clear cell ICC

Intrahepatic cholangiocarcinoma is a cancer of the bile duct in the liver. The clear cell subtype of ICC is a rare cancer; until now, only 8 cases have been reported. The number of reports is so small that a detail description of clear cell ICC is valuable.

3 Jun 2010

Biovail: BLS, Kyowa Hakko Kirin sign license agreement

Biovail Corporation today announced that its subsidiary, Biovail Laboratories International SRL, has entered into a license agreement with Kyowa Hakko Kirin Co., Ltd. BLS has acquired the U.S. and Canadian rights to commercialize products containing istradefylline - a new chemical entity targeted for the treatment of Parkinson's disease.

3 Jun 2010

Study: Shortened hospital stays may bring increased risks of return

"To save costs, hospitals for years have been discharging patients after shorter stays. But at the same time more people are having to return to hospital for additional care within a month of their initial treatment, according to a major new study of Medicare heart-failure patients."

3 Jun 2010

Medical marijuana hydroponics nutrients receive official US approval

In a landmark decision, Oregon regulators have given first-ever official US approval to a brand of medical marijuana hydroponics nutrients. Oregon and most other states have regulatory agencies that examine fertilizers and hydroponics plant supplements to determine the legitimacy, ingredients and effectiveness of plant growth products.

3 Jun 2010

FDA issues letter directing GSK to revise product labeling for Serevent and Advair

GlaxoSmithKline today announced that it has received a letter from the U.S. Food and Drug Administration directing revisions to product labeling for its respiratory products Serevent and Advair. The letter concludes discussions between GSK and the agency following FDA advisory committee meetings regarding the safety profile of long-acting beta2-agonists in the treatment of asthma, including salmeterol, the active ingredient in Serevent and one of the active ingredients in Advair.

3 Jun 2010

Medtronic spent $1.07 million in first-quarter lobbying

Medical device giant Medtronic spent $1.07 million in the first quarter of the year to lobby Congress, including on health issues such as a provision of the new overhaul law that will extract up to $3 billion a year in fees from device makers, The Associated Press/Bloomberg Businessweek reports.

3 Jun 2010

Motavizumab should not be licensed for marketing: FDA Antiviral Drugs Advisory Committee

MedImmune today announced that the U.S. Food and Drug Administration's Antiviral Drugs Advisory Committee has voted 14 to 3 to recommend that motavizumab should not be licensed for marketing regarding the prevention of serious respiratory syncytial virus disease in high-risk infants.

3 Jun 2010

Scientists awarded $3.9M grant to study how XDR-TB transmitted in rural South Africa

The National Institutes of Health has awarded scientists at Albert Einstein College of Medicine of Yeshiva University a five-year, $3.9 million grant to study how extensively drug-resistant tuberculosis is transmitted in rural South Africa. The findings could alter public health approaches for controlling the XDR-TB epidemic in the developing world.

3 Jun 2010

Phase II trial of NUVIGIL Tablets for treatment of schizophrenia fails to meet primary endpoint: Cephalon

Cephalon, Inc. today announced that the primary endpoint was not met in a Phase II clinical trial that examined NUVIGIL (armodafinil) Tablets [C-IV] as an adjunctive therapy for the treatment of the negative symptoms of schizophrenia, which include problems with motivation and emotional withdrawal.

3 Jun 2010

Beacon Partners study uncovers how healthcare organizations impacted by economy

Healthcare management consulting firm Beacon Partners recently conducted a study of healthcare executives nationwide resulting in over 200 responding to a survey uncovering how their healthcare organizations have been impacted by the economy.

3 Jun 2010

Loophole in CHIP costs feds millions in lost revenue

"A tobacco tax loophole in President Barack Obama's children's health insurance program cost the government more than $250 million in its first year, public health officials say. The loophole allowed companies to avoid huge tax increases on loose rolling tobacco by relabeling their product as pipe tobacco. The simple marketing twist lets companies pay $2.83 per pound, rather than the $24.78 per pound levied on rolling tobacco. That proved an expensive technicality in the way the government pays for health insurance for poor children."

3 Jun 2010

ACT Biotech's Telatinib receives orphan drug designation from FDA for treatment of gastric cancer

ACT Biotech Inc., a privately held biotechnology company developing a portfolio of oral kinase inhibitors as anti-cancer drugs, announced today that the company's highly selective oral kinase inhibitor, Telatinib, has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of gastric cancer.

3 Jun 2010

Medical News

STARR procedure proposed as alternative operation, noninvasive surgical technique for ODS

Radiation therapy may not improve chances of survival for bladder cancer patients: Study

Extracts from peach and plum kill breast cancer cells, say AgriLife Research scientists

Ocutec receives further equity investment of £500K from existing investors

U-M researchers one step closer to discovering why certain diseases affect specific organs

Data on Nanosphere Verisens PSA assay to be presented at AUA annual meeting

Miners' living, working environments fuel spread of TB in sub-Saharan Africa, study says

Life Technologies, DKFZ collaborate to create National High-Throughput Sequencing Center

Case report on clear cell ICC

Biovail: BLS, Kyowa Hakko Kirin sign license agreement

Study: Shortened hospital stays may bring increased risks of return

Medical marijuana hydroponics nutrients receive official US approval

FDA issues letter directing GSK to revise product labeling for Serevent and Advair

Medtronic spent $1.07 million in first-quarter lobbying

Motavizumab should not be licensed for marketing: FDA Antiviral Drugs Advisory Committee

Scientists awarded $3.9M grant to study how XDR-TB transmitted in rural South Africa

Phase II trial of NUVIGIL Tablets for treatment of schizophrenia fails to meet primary endpoint: Cephalon

Beacon Partners study uncovers how healthcare organizations impacted by economy

Loophole in CHIP costs feds millions in lost revenue

ACT Biotech's Telatinib receives orphan drug designation from FDA for treatment of gastric cancer

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News